Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Monon Bioventures
AddedFeb 18, 2024
UpdatedJun 18, 2026
Monon Bioventures

Monon Bioventures

Angel

Monon Bioventures: Transforming research into valuable assets for investors and corporate partners.

HQ
Fishers, IN, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded to assist world-class investigators in translating their research into clinical applications, Monon Bioventures (MBV) is a privately held company with a core mission to transform innovative ideas into valuable assets. MBV focuses on providing the necessary support to overcome early-stage challenges, ensuring that groundbreaking research can attract follow-on capital from angel investors, venture capitalists, and strategic corporate partners. Their market focus lies in bridging the gap between scientific discovery and practical, marketable solutions in the healthcare sector.

Notable affiliated individuals and investors include leading scientists and experienced venture capitalists who bring a wealth of expertise to the table. Key achievements of Monon Bioventures include successfully guiding several research projects through early development stages and securing significant investments for their commercialization. The overall impact of MBV is seen in its ability to accelerate the transition of innovative healthcare solutions from the lab to the clinic, thereby improving lives through advanced medical technologies.

Monon Bioventures - Quick Facts

When was Monon Bioventures founded?

Monon Bioventures was founded in 2015.

Where is Monon Bioventures' headquarters located?

Monon Bioventures' headquarters is located in Fishers, IN, US.

When was Monon Bioventures' last funding round?

Monon Bioventures' most recent funding round was for $398.3k (USD) in September 2022.

How much has Monon Bioventures raised to-date?

As of Sep 22, 2022, Monon Bioventures has raised a total of $398.3k (USD).

How many employees does Monon Bioventures have?

Monon Bioventures has 2 employees as of Feb 4, 2024.

Monon Bioventures - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Investment
Tags
  • Biotech
  • Consulting